{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T22:20:31Z","timestamp":1775341231467,"version":"3.50.1"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002912","name":"Government of Guangdong Province","doi-asserted-by":"publisher","award":["A1-2601-21-414-001Z06"],"award-info":[{"award-number":["A1-2601-21-414-001Z06"]}],"id":[{"id":"10.13039\/501100002912","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.intimp.2024.111490","type":"journal-article","created":{"date-parts":[[2024,1,13]],"date-time":"2024-01-13T16:27:31Z","timestamp":1705163251000},"page":"111490","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Hypersampsonone H attenuates ulcerative colitis via inhibition of PDE4 and regulation of cAMP\/PKA\/CREB signaling pathway"],"prefix":"10.1016","volume":"128","author":[{"given":"Yanzhen","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingqiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianhui","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruimin","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6991-5805","authenticated-orcid":false,"given":"Zhongxiang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhanghua","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.intimp.2024.111490_b0005","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41575-022-00604-y","article-title":"Mechanisms of mucosal healing: Treating inflammatory bowel disease without immunosuppression?","volume":"19","author":"Villablanca","year":"2022","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"10080","key":"10.1016\/j.intimp.2024.111490_b0010","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1016\/S0140-6736(16)32126-2","article-title":"Ulcerative colitis","volume":"389","author":"Ungaro","year":"2017","journal-title":"Lancet (london, England)"},{"key":"10.1016\/j.intimp.2024.111490_b0015","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.ebiom.2018.03.030","article-title":"Sodium butyrate inhibits inflammation and maintains epithelium barrier integrity in a TNBS-induced inflammatory bowel disease mice model","volume":"30","author":"Chen","year":"2018","journal-title":"EBioMedicine."},{"issue":"4","key":"10.1016\/j.intimp.2024.111490_b0020","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.gtc.2020.07.005","article-title":"Epidemiology and pathogenesis of ulcerative colitis","volume":"49","author":"Du","year":"2020","journal-title":"Clin. Gastroenterol."},{"issue":"1","key":"10.1016\/j.intimp.2024.111490_b0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1515\/jbcpp-2018-0036","article-title":"Immune response and inflammatory pathway of ulcerative colitis","volume":"30","author":"Tatiya-Aphiradee","year":"2018","journal-title":"J. Basic Clin. Physiol. Pharmacol."},{"key":"10.1016\/j.intimp.2024.111490_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.114086","article-title":"The role and mechanism of flavonoid herbal natural products in ulcerative colitis","volume":"158","author":"Xue","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"3","key":"10.1016\/j.intimp.2024.111490_b0035","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1080\/17474124.2021.1840976","article-title":"Epidemiology, burden of disease, and unmet needs in the treatment of ulcerative colitis in Asia","volume":"15","author":"Wei","year":"2021","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"issue":"11","key":"10.1016\/j.intimp.2024.111490_b0040","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/nrgastro.2016.116","article-title":"Acute severe ulcerative colitis: from pathophysiology to clinical management","volume":"13","author":"Hindryckx","year":"2016","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.intimp.2024.111490_b0045","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/nyas.13414","article-title":"Biological and clinical implications of herbal medicine and natural products for the treatment of inflammatory bowel disease","volume":"1401","author":"Guo","year":"2017","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"5","key":"10.1016\/j.intimp.2024.111490_b0050","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1111\/bph.12333","article-title":"Penta-O-galloyl-\u03b2-D-glucose ameliorates inflammation by inhibiting MyD88\/NF-\u03baB and MyD88\/MAPK signalling pathways","volume":"170","author":"Jang","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.intimp.2024.111490_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.123241","article-title":"Cordyceps militaris polysaccharide alleviates diabetic symptoms by regulating gut microbiota against TLR4\/NF-\u03baB pathway","volume":"230","author":"Zhao","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.intimp.2024.111490_b0060","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.3389\/fimmu.2017.01882","article-title":"Gut microbiota dysbiosis drives and implies novel therapeutic strategies for diabetes mellitus and related metabolic diseases","volume":"8","author":"Li","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2024.111490_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104978","article-title":"Evodiamine has therapeutic efficacy in ulcerative colitis by increasing Lactobacillus acidophilus levels and acetate production","volume":"159","author":"Wang","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.intimp.2024.111490_b0070","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.3389\/fimmu.2018.02907","article-title":"Transcription factor ZNF281: A novel player in intestinal inflammation and fibrosis","volume":"9","author":"Pierdomenico","year":"2018","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2024.111490_b0075","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1089\/ars.2015.6611","article-title":"Advanced oxidation protein products induce epithelial-mesenchymal transition of intestinal epithelial cells via a PKC \u03b4-mediated, redox-dependent signaling pathway","volume":"27","author":"Xu","year":"2017","journal-title":"Antioxid. Redox Signaling."},{"issue":"9","key":"10.1016\/j.intimp.2024.111490_b0080","doi-asserted-by":"crossref","first-page":"8135","DOI":"10.3390\/ijms24098135","article-title":"Unleashing spinal cord repair: The role of cAMP-specific PDE inhibition in attenuating neuroinflammation and boosting regeneration after traumatic spinal cord injury","volume":"24","author":"Mussen","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"19","key":"10.1016\/j.intimp.2024.111490_b0085","doi-asserted-by":"crossref","first-page":"10594","DOI":"10.1021\/acs.jmedchem.9b02170","article-title":"Advances in the development of phosphodiesterase-4 inhibitors","volume":"63","author":"Peng","year":"2020","journal-title":"J. Med. Chem."},{"issue":"13","key":"10.1016\/j.intimp.2024.111490_b0090","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1111\/bph.14667","article-title":"Inhibition of phosphodiesterase-4 attenuates murine ulcerative colitis through interference with mucosal immunity","volume":"176","author":"Li","year":"2019","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2024.111490_b0095","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.apsb.2021.04.007","article-title":"Targeting PDE4 as a promising therapeutic strategy in chronic ulcerative colitis through modulating mucosal homeostasis","volume":"12","author":"Li","year":"2022","journal-title":"Acta Pharm. Sin. B."},{"issue":"3","key":"10.1016\/j.intimp.2024.111490_b0100","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.crohns.2009.03.001","article-title":"CC-10004 but not thalidomide or lenalidomide inhibits lamina propria mononuclear cell TNF-\u03b1 and MMP-3 production in patients with inflammatory bowel disease","volume":"3","author":"Gordon","year":"2009","journal-title":"J Crohns Colitis."},{"key":"10.1016\/j.intimp.2024.111490_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2021.153709","article-title":"A recent update on the use of Chinese medicine in the treatment of inflammatory bowel disease","volume":"92","author":"Yang","year":"2021","journal-title":"Phytomedicine."},{"issue":"1","key":"10.1016\/j.intimp.2024.111490_b0110","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jep.2012.12.013","article-title":"Naturally derived anti-inflammatory compounds from Chinese medicinal plants","volume":"146","author":"Wang","year":"2013","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.intimp.2024.111490_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2020.112686","article-title":"Ethnopharmacology of Hypericum species in China: A comprehensive review on ethnobotany, phytochemistry and pharmacology","volume":"254","author":"Zhang","year":"2020","journal-title":"J. Ethnopharmacol."},{"issue":"7","key":"10.1016\/j.intimp.2024.111490_b0120","doi-asserted-by":"crossref","first-page":"3508","DOI":"10.1021\/acs.chemrev.7b00551","article-title":"Research progress of polycyclic polyprenylated acylphloroglucinols","volume":"118","author":"Yang","year":"2018","journal-title":"Chem. Rev."},{"issue":"58","key":"10.1016\/j.intimp.2024.111490_b0125","doi-asserted-by":"crossref","first-page":"53469","DOI":"10.1039\/C6RA08805H","article-title":"Polycyclic polyprenylated acylphloroglucinols: natural phosphodiesterase-4 inhibitors from Hypericum sampsonii","volume":"6","author":"Zhang","year":"2016","journal-title":"RSC Adv."},{"key":"10.1016\/j.intimp.2024.111490_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2022.115447","article-title":"Hypericum sampsonii attenuates inflammation in mice with ulcerative colitis via regulation of PDE4\/PKA\/CREB signaling pathway","volume":"296","author":"Lin","year":"2022","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.intimp.2024.111490_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.fitote.2023.105610","article-title":"Polycyclic polyprenylated acylphloroglucinols from Hypericum sampsonii Hance and their anti-inflammatory activity","volume":"169","author":"Li","year":"2023","journal-title":"Fitoterapia."},{"key":"10.1016\/j.intimp.2024.111490_b0140","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ejmech.2019.03.013","article-title":"Synthesis and evaluation of tetrahydroquinolin-2(1H)-one derivatives as novel anti-pancreatic cancer agents via targeting autophagy","volume":"170","author":"Shen","year":"2019","journal-title":"Eur. J. Med. Chem."},{"issue":"3","key":"10.1016\/j.intimp.2024.111490_b0145","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.apsb.2019.08.006","article-title":"Protective role of berberine on ulcerative colitis through modulating enteric glial cells-intestinal epithelial cells-immune cells interactions","volume":"10","author":"Li","year":"2020","journal-title":"Acta Pharm. Sin. B."},{"issue":"4","key":"10.1016\/j.intimp.2024.111490_b0150","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1002\/ptr.7689","article-title":"Protective effects of 4-geranyloxy-2,6-dihydroxybenzophenonel on DSS-induced ulcerative colitis in mice via regulation of cAMP\/PKA\/CREB and NF-\u03baB signaling pathways","volume":"37","author":"Wang","year":"2023","journal-title":"Phytother. Res."},{"issue":"1","key":"10.1016\/j.intimp.2024.111490_b0155","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1053\/j.gastro.2005.05.019","article-title":"Growth hormone reduces the severity of fibrosis associated with chronic intestinal inflammation","volume":"129","author":"Theiss","year":"2005","journal-title":"Gastroenterology."},{"issue":"9","key":"10.1016\/j.intimp.2024.111490_b0160","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1038\/s41419-020-02969-x","article-title":"Inhibition of the activation of \u03b3\u03b4T17 cells through PPAR\u03b3-PTEN\/Akt\/GSK3\u03b2\/NFAT pathway contributes to the anti-colitis effect of madecassic acid","volume":"11","author":"Yun","year":"2020","journal-title":"Cell Death Dis."},{"issue":"11","key":"10.1016\/j.intimp.2024.111490_b0165","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1093\/ecco-jcc\/jjv133","article-title":"Development of fibrosis in acute and longstanding ulcerative colitis","volume":"9","author":"de Bruyn","year":"2015","journal-title":"J Crohns Colitis."},{"issue":"6","key":"10.1016\/j.intimp.2024.111490_b0170","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.gie.2018.08.018","article-title":"The emerging role of histologic disease activity assessment in ulcerative colitis","volume":"88","author":"Pai","year":"2018","journal-title":"Gastrointest. Endosc."},{"key":"10.1016\/j.intimp.2024.111490_b0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2020.153179","article-title":"Wogonoside alleviates colitis by improving intestinal epithelial barrier function via the MLCK\/pMLC2 pathway","volume":"68","author":"Huang","year":"2020","journal-title":"Phytomedicine."},{"issue":"3","key":"10.1016\/j.intimp.2024.111490_b0180","doi-asserted-by":"crossref","first-page":"41","DOI":"10.12677\/HJCB.2018.83006","article-title":"Study of E-oligoresveratrol compounds bactericidal mechanism based on reversed docking","volume":"8","author":"Lv","year":"2018","journal-title":"Hans J. Comput. Biol."},{"key":"10.1016\/j.intimp.2024.111490_b0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154415","article-title":"Perillyl alcohol attenuates chronic restraint stress aggravated dextran sulfate sodium-induced ulcerative colitis by modulating TLR4\/NF-\u03baB and JAK2\/STAT3 signaling pathways","volume":"106","author":"Puppala","year":"2022","journal-title":"Phytomedicine."},{"key":"10.1016\/j.intimp.2024.111490_b0190","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.986510","article-title":"Trypsin inhibitor LH011 inhibited DSS-induced mice colitis via alleviating inflammation and oxidative stress","volume":"13","author":"Jia","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"3","key":"10.1016\/j.intimp.2024.111490_b0195","doi-asserted-by":"crossref","first-page":"353","DOI":"10.4292\/wjgpt.v7.i3.353","article-title":"Overview of cytokines and nitric oxide involvement in immuno-pathogenesis of inflammatory bowel diseases","volume":"7","author":"Soufli","year":"2016","journal-title":"World J. Gastrointest. Pharmacol. Ther."},{"issue":"10","key":"10.1016\/j.intimp.2024.111490_b0200","doi-asserted-by":"crossref","first-page":"5861","DOI":"10.1002\/ptr.7246","article-title":"Therapeutic potential of isobavachalcone, a natural flavonoid, in murine experimental colitis by inhibiting NF-\u03baB p65","volume":"35","author":"Zhou","year":"2021","journal-title":"Phytother. Res."},{"issue":"6","key":"10.1016\/j.intimp.2024.111490_b0205","first-page":"1248","article-title":"Quality of methods reporting in animal models of colitis","volume":"21","author":"Bramhall","year":"2015","journal-title":"Inflamm Bowel Dis."},{"key":"10.1016\/j.intimp.2024.111490_b0210","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.ebiom.2019.06.033","article-title":"Therapeutic ultrasound attenuates DSS-induced colitis through the cholinergic anti-inflammatory pathway","volume":"45","author":"Nunes","year":"2019","journal-title":"EBioMedicine."},{"key":"10.1016\/j.intimp.2024.111490_b0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102441","article-title":"Mo3Se4 nanoparticle with ROS scavenging and multi-enzyme activity for the treatment of DSS-induced colitis in mice","volume":"56","author":"Guo","year":"2022","journal-title":"Redox Biol."},{"key":"10.1016\/j.intimp.2024.111490_b0220","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.intimp.2018.01.004","article-title":"Roflumilast, type 4 phosphodiesterase inhibitor, attenuates inflammation in rats with ulcerative colitis via down-regulation of iNOS and elevation of cAMP","volume":"56","author":"El-Ashmawy","year":"2018","journal-title":"Int. Immunopharmacol."},{"issue":"9","key":"10.1016\/j.intimp.2024.111490_b0225","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1517\/13543784.16.9.1489","article-title":"Phosphodiesterase 4 inhibitors and inflammatory bowel disease: Emerging therapies in inflammatory bowel disease","volume":"16","author":"Keshavarzian","year":"2007","journal-title":"Expert Opin. on Invest. Drugs."},{"issue":"1","key":"10.1016\/j.intimp.2024.111490_b0230","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jcmgh.2017.03.007","article-title":"Mend your fences: The epithelial barrier and its relationship with mucosal immunity in inflammatory bowel disease","volume":"4","author":"Martini","year":"2017","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"issue":"11","key":"10.1016\/j.intimp.2024.111490_b0235","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.3748\/wjg.v22.i11.3117","article-title":"Tight junctions in inflammatory bowel diseases and inflammatory bowel disease associated colorectal cancer","volume":"22","author":"Landy","year":"2016","journal-title":"World J. Gastroenterol."},{"issue":"5","key":"10.1016\/j.intimp.2024.111490_b0240","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202202108R","article-title":"Cholinergic drugs reduce metabolic inflammation and diabetic myocardial injury by regulating the gut bacterial component lipopolysaccharide-induced ERK\/Egr-1 pathway","volume":"37","author":"Wu","year":"2023","journal-title":"FASEB J."},{"issue":"10","key":"10.1016\/j.intimp.2024.111490_b0245","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000082","article-title":"Fibrosis mediators in the colonic mucosa of acute and healed ulcerative colitis","volume":"10","author":"Gundersen","year":"2019","journal-title":"Clin. Transl. Gastroenterol."},{"issue":"12","key":"10.1016\/j.intimp.2024.111490_b0250","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/j.bcp.2012.01.001","article-title":"Apremilast mechanism of action and application to psoriasis and psoriatic arthritis","volume":"83","author":"Schafer","year":"2012","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.intimp.2024.111490_b0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115195","article-title":"Advances in the development of phosphodiesterase-4 inhibitors","volume":"250","author":"Li","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.intimp.2024.111490_b0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2022.116020","article-title":"Sappanone A: A natural PDE4 inhibitor with dual anti-inflammatory and antioxidant activities from the heartwood of Caesalpinia sappan L","volume":"304","author":"Wang","year":"2023","journal-title":"J. Ethnopharmacol."},{"issue":"7","key":"10.1016\/j.intimp.2024.111490_b0265","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1080\/17460441.2016.1190706","article-title":"Using reverse docking for target identification and its applications for drug discovery","volume":"11","author":"Lee","year":"2016","journal-title":"Expert Opin. Drug Discovery."},{"key":"10.1016\/j.intimp.2024.111490_b0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.113958","article-title":"DC591017, a phosphodiesterase-4 (PDE4) inhibitor with robust anti-inflammation through regulating PKA-CREB signaling","volume":"177","author":"Li","year":"2020","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2024.111490_b0275","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1124\/jpet.116.239608","article-title":"Novel phosphodiesterase 4 inhibitor FCPR03 alleviates lipopolysaccharide-induced neuroinflammation by regulation of the cAMP\/PKA\/CREB signaling pathway and NF-\u03baB inhibition","volume":"362","author":"Zou","year":"2017","journal-title":"J. Pharmacol. Exp. Ther."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924000079?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924000079?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T18:16:46Z","timestamp":1761589006000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576924000079"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":55,"alternative-id":["S1567576924000079"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.111490","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hypersampsonone H attenuates ulcerative colitis via inhibition of PDE4 and regulation of cAMP\/PKA\/CREB signaling pathway","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.111490","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"111490"}}